China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Qiagen and Illumina just made a huge commitment to one another. The two companies announced a 15-year partnership to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient managem

Researchers from the University of Strathclyde have developed a blood test that could help to accelerate the diagnosis of brain cancer. The technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial

DiaSorin Molecular has received CE mark for an assay that detects DNA of varicella-zoster virus (VZV) directly from swab specimens, the firm announced today.

Illumina plans to lay off 58 employees, according to documents filed with the State of California Employment Development Department.

PerkinElmer said after the close of the market on Tuesday that it has entered into an agreement for a new $1 billion unsecured revolving credit facility available through Sept. 17, 2024.

Roche announced today its cobas Babesia blood test for individual blood donation testing has received marketing approval from the US Food and Drug Administration.

Thermo Fisher Scientific today priced an underwritten offering of a series of euro- and dollar-denominated senior notes, in an aggregate principal amount of $5.7 billion.

Diagnostics developer DiamiR said today that it has received an additional $345,000 in grant funding from the National Institute on Aging to develop a microRNA-based test for early-stage Alzheimer's disease.

The global immunoassay market is projected to grow at a CAGR of 5.9% from 2019 to reach USD 19.76 billion by 2025, driven by increasing incidences of chronic and infectious diseases

Bio-Rad Laboratories yesterday filed another lawsuit accusing 10x Genomics of patent infringement.